Safety and Performance Study of the INGEVITY Lead
A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 1060 participants.
Also called NCT01688843
- Study
- In this atlas
Overview
- Design
- Interventional study; allocation not applicable; no masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 1,060 participants
- Sponsor
- Registry
-
NCT01688843
-
- Start date
- (registry gives no type)
- Primary completion
- (actual)
- Completion
- (actual)
- Results first posted
- Countries
- United States, Australia, Austria, Belgium, Canada, Denmark, France, Germany, Hong Kong SAR China, Italy, Malaysia, Portugal, Spain, Sweden, Thailand, United Kingdom
- Registry status
- Completed
Technical summary
Registry record NCT01688843. Allocation not applicable; no masking; primary purpose treatment. Start 2012-10 (registry gives no type); primary completion 2015-01 (actual). Results posted on 2017-11-17.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Safety and Performance Study of the INGEVITY Lead
- Condition
- Bradycardia
- Condition
- Sinus Node Dysfunction
- Intervention (Device)
- INGEVITY lead
- Lead sponsor
- Boston Scientific Corporation
Record details
- Record id
cardio:ct-nct01688843- Content hash
3ea23441c73013465a7928a57f1c8a0eaaa2cb66789384e3c41a1baac9358de7